Crossmark

In vitro and in vivo delivery of a sustained release nanocarrier-based formulation of an MRTF/SRF inhibitor in conjunctival fibrosis

Crossref DOI link: https://doi.org/10.1186/s12951-018-0425-3

Published Online: 2018-11-27

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tagalakis, Aristides D.

Madaan, Shivam

Larsen, Scott D.

Neubig, Richard R.

Khaw, Peng T.

Rodrigues, Ian

Goyal, Saurabh

Lim, Kin Sheng

Yu-Wai-Man, Cynthia https://orcid.org/0000-0003-4868-5187
Funding

Funding for this research was provided by:

Medical Research Council (535333)

Moorfields Eye Charity

National Institute for Health Research
License Information

Text and Data Mining valid from 2018-11-27
More Information

Article History

Received: 9 May 2018

Accepted: 21 November 2018

First Online: 27 November 2018